Causes of postoperative mortality after surgery for ovarian cancer

European Journal of Cancer

Volumn 45, Issue 16, 2009, Pages 2799-2803

  Gerestein, C G ^a,c   Damhuis, R A M ^b   de Vries, M ^a   Reedijk, A ^b   Burger, C W ^c   Kooi, G S ^a  

^a ALBERT SCHWEITZER HOSPITAL   (Netherlands)

^b Integraal Kankercentrum Rotterdam   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cytoreductive surgery; Ovarian cancer; Postoperative mortality

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SURGERY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN TISSUE; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; OVARY CANCER; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL INFECTION;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM, RESIDUAL; NETHERLANDS; OVARIAN NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PREVALENCE; YOUNG ADULT;

EID: 70350637356     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.06.004     Document Type: Article

References (17)

1. Bristow R.E., Tomacruz R.S., Armstrong D.K., Trimble E.L., and Montz F.J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20 5 (2002) 1248-1259
2. Tingulstad S., Skjeldestad F.E., Halvorsen T.B., and Hagen B. Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol 101 5 Pt 1 (2003) 885-891
3. du Bois A., Reuss A., Pujade-Lauraine E., et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). Cancer 115 6 (2009) 1234-1244
4. Chen S.S., and Bochner R. Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinoma. Gynecol Oncol 20 2 (1985) 190-195
5. Heintz A.P., Hacker N.F., Berek J.S., et al. Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity. Obstet Gynecol 67 6 (1986) 783-788
6. Aletti G.D., Santillan A., Eisenhauer E.L., et al. A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model. Gynecol Oncol 107 1 (2007) 99-106
7. Alphs H.H., Zahurak M.L., Bristow R.E., and Diaz-Montes T.P. Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer. Gynecol Oncol 103 3 (2006) 1048-1053
8. Gerestein C.G., Damhuis R.A., Burger C.W., and Kooi G.S. Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: a systematic review. Gynecol Oncol (2009)
9. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 5 (1987) 373-383
10. Changes in definitions of clinical staging for carcinoma of the cervix and ovary: International Federation of Gynecology and Obstetrics. Am J Obstet Gynecol 1987;156(1):263-4.
11. Khuri S.F., Daley J., Henderson W., et al. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg 228 4 (1998) 491-507
12. Waljee J.F., Windisch S., Finks J.F., Wong S.L., and Birkmeyer J.D. Classifying cause of death after cancer surgery. Surg Innov 13 4 (2006) 274-279
13. Diaz-Montes T.P., Zahurak M.L., Giuntoli II R.L., et al. Surgical care of elderly women with ovarian cancer: a population-based perspective. Gynecol Oncol 99 2 (2005) 352-357
14. Vernooij F., Heintz P., Witteveen E., and van der Graaf Y. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol Oncol 105 3 (2007) 801-812
15. Engelen M.J., Kos H.E., Willemse P.H., et al. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 106 3 (2006) 589-598
16. Earle C.C., Schrag D., Neville B.A., et al. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst 98 3 (2006) 172-180
17. Wimberger P., Lehmann N., Kimmig R., et al. Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol 100 2 (2006) 300-307